Johnson & Johnson accused of failing to warn patients at higher risk from vaginal mesh

The Guardian -------- The pharmaceutical giant Johnson & Johnson allegedly failed to warn women that its vaginal mesh devices posed a particular risk for patients with compromised immune systems, despite it being “well known” before they were first sold in Australia. The federal court is currently deliberating on a landmark class action involving hundreds of women who have sued the multinational giant over the impact of its vaginal mesh devices. The mesh was surgically implanted to treat stress urinary incontinence and pelvic organ prolapse, common complications of childbirth. It was marketed to surgeons as a simple, safe and affordable implant, which would boost their profits and speed up operations considerably. To learn more click on the picture below to read the article.